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Abstract
Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3
(Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1–4.
Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and
function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the
forkhead box O (Foxo) family of transcription factors6–10. However, whether Foxo proteins act
beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains
largely unexplored. Here we show that Foxo1 is a pivotal regulatorof Treg cell function. Treg cells
express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1
phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1
develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but
without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ~300 Foxo1-
bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly
regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling
module controls a novel genetic program indispensable for Treg cell function.
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Among the three Foxo genes expressed in T cells, the transcript of Foxo1 is specifically
upregulated in mature thymocytes8. To genetically mark cells expressing Foxo1, we
engineered a Foxo1 allele (Foxo1tag) encoding an in-frame fusion protein tag containing
green fluorescent protein (GFP), Flag and a biotin-labelling peptide that enables Foxo1
biotinylation in birA-transgenic mice that express the bacterial biotin ligase BirA (Fig. 1a
and Supplementary Fig. 1). T-cell expression of CD127 (also known as Il7r), the product of
a previously identified Foxo1 target gene11,12, was unaffected in Foxo1tag/tag mice
(Supplementary Fig. 1d), indicating that the protein tag does not alter Foxo1 function. Using
GFP as a reporter, we found that immature thymocytes expressed low amounts of Foxo1
(Fig. 1a). Foxo1 was more strongly upregulated in Treg cells than in conventional CD4+ T
cells in the thymus, whereas the peripheral T cells expressed similar amounts of Foxo1 (Fig.
1a).
Foxo1 resides in the nucleus of quiescent T cells, and relocates to the cytosol after T-cell
receptor (TCR) stimulation. To investigate the kinetics of Foxo1 translocation, we
performed live-imaging experiments on CD4+ T cells from Foxo1tag/tag mice on a Foxp3-
internal ribosome entry site (IRES)-red fluorescent protein (RFP)-transgenic background in
which Treg cells are marked by the expression of RFP. Whereas high-dose CD3 antibody
induced Foxo1 nuclear clearance in all T cells (Fig. 1b, c and Supplementary Video 1), low-
dose CD3 antibody triggered Foxo1 translocation in conventional T cells but not in Treg
cells (Fig. 1b, c and Supplementary Video 2). Attenuated Foxo1 nuclear clearance in Treg
cells was further revealed by the immunostaining of T cells from wild-type mice
(Supplementary Fig. 2a, b). Foxo1 nuclear export is regulated by Akt-induced Foxo1
phosphorylation. Low-dose anti-CD3 induced robust Akt and Foxo1 phosphorylation in
conventionalT cells, which was markedly decreased in Treg cells (Fig. 1d). The
phosphorylation defects of Foxo1 and Akt were less profound in T cells stimulated with
high-dose CD3 antibody (Supplementary Fig. 2c). Anti-CD3-induced Erk1 and Erk2 (also
known as Mapk3 and Mapk1, respectively) phosphorylation was not compromised at the
late time points in Treg cells (Fig. 1d and Supplementary Fig. 2c), suggesting that the Akt
pathway might be specifically modulated, probably through high expression of the Akt
phosphatase Phlpp1 (ref. 13). Thus, compared to conventional T cells, Treg cells are resistant
to TCR-induced Akt activation and Foxo1 nuclear clearance.
To investigate the function of Foxo1 in Treg cells, we crossed mice carrying floxed Foxo1
alleles (Foxo1fl/fl) with Foxp3cre mice14. Foxo1 protein was barely detectable in Treg cells
from Foxp3cre Foxo1fl/fl mice, whereas conventional CD4+ T cells from Foxp3cre Foxo1fl/fl
mice expressed comparable amounts of Foxo1 to wild-type T cells (Fig. 2a). In the absence
of Foxo1 in Treg cells, mice developed a hunched posture associated with lack of mobility,
in addition to crusting of the ears, eyelids and tail (Fig. 2b) before they became moribund
within 35 days of birth. Such a fulminant phenotype was comparable in severity to that of
mice with the scurfy mutation of the Foxp3 gene (Foxp3sf; Fig. 2b), or mice depleted of Treg
cells15,16. In addition, Foxp3cre Foxo1fl/fl mice showed splenomegaly and lymphadenopathy
(Fig. 2c), and had a dense infiltrate of leukocytes in the salivary glands, lung interstitia, liver
sinusoids, pancreas acini, stomach, and colon mucosa (Fig. 2d).
The severe immunopathology was associated with the expansion of T-cell populations
expressing high amounts of the cell-proliferation marker Ki67 (Fig. 2e and Supplementary
Fig. 3). T cells displayed an effector/memory phenotype (Fig. 2f and Supplementary Fig. 4a)
and produced increased amounts of the pro-inflammatory cytokine interferon (IFN)-γ (Fig.
2g and supplementary Fig. 4b). Deletion of Foxo1 from CD4+CD8+ immature T cells results
in compromised Treg cell differentiation8,10. However, thymic and splenic Treg cell numbers
were unaffected in 12-day-old Foxp3cre Foxo1fl/fl mice (Supplementary Fig. 5). By the age
of day 20, Treg cell numbers in the peripheral lymphoid tissues were increased in
Ouyang et al. Page 2
Nature. Author manuscript; available in PMC 2013 September 12.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Foxp3cre Foxo1fl/fl mice (Fig. 2h and Supplementary Fig. 4c). These findings imply that the
lymphoproliferative disease is caused by a loss of Treg cell function rather than a loss of Treg
cells.
The observation that Treg cells were less sensitive to TCR-induced Foxo1 nuclear exclusion
implies that Foxo1-dependent transcriptional regulation is crucial for Treg cell function.
However, cytosolic Foxo1 regulates autophagy through transcription-independent
mechanisms17. To differentiate the activities of nuclear Foxo1 and cytosolic Foxo1 induced
by Akt activation, we inserted a complementary DNA fragment coding for a haemagglutinin
(HA)-tagged human Foxo1 mutant in which amino acids at the Akt phosphorylation sites
were substituted with alanines18 (HA-hFoxo1(AAA)), preceded by a loxP-flanked `neo-
STOP' cassette into the Rosa26 locus (Supplementary Fig. 6). Mice carrying the mutant
allele (Foxo1AAA) were crossed with oestrogen receptor-Cre (creER) mice. Wild-type T
cells or T cells from creER Foxo1AAA/+ mice previously treated with tamoxifen to induce
HA-hFoxo1(AAA) expression were stimulated with CD3 and CD28 antibodies. As
expected, whereas wild-type Foxo1 translocated from the nucleus to the cytosol, the HA-
hFoxo1(AAA)-expressing mutant was defective in nuclear export (Supplementary Fig. 6c).
We further crossed Foxo1AAA/+ mice with Foxp3cre mice, and confirmed specific HA-
hFoxo1(AAA) expression in Treg cells (Fig. 3a). Ectopic expression of HA-hFoxo1(AAA)
did not affect Treg cell differentiation or homeostasis (Supplementary Fig. 7a). Upon
breeding the Foxo1AAA allele to Foxp3cre Foxo1fl/fl mice, the lethal inflammatory phenotype
was completely rescued (Fig. 3b and supplementary Fig. 7), indicating that the Treg cell
defects are caused by a loss of nuclear Foxo1 activity.
For global identification of Foxo1 DNA-binding sites in Treg cells, we performed chromatin
immunoprecipitation coupled to high-throughput sequencing (ChIP-seq) experiments using
Foxo1 antibody precipitation of chromatin purified from CD4+CD25+ T cells from C57BL/6
mice, or streptavidin pull-down of chromatin from Treg cells of Foxo1tag/tag birA mice. To
define a ChIP-seq peak as significant, we used the model-based analysis of ChIP-seq
(MACS) peak calling software and applied an empirical false-discovery rate of 0.01 at
which the noise ratio of peak detection was less than 0.005 (Supplementary Fig. 8a). Using
this criterion, we identified 3,431 enriched genomic loci that were shared between the
antibody and the biotinylated Foxo1 samples (Supplementary Fig. 8b), and were designated
as putative Foxo1 binding sites (Supplementary Table 1). Among the Foxo1binding peaks,
we could identify previously characterized binding sites of Foxo1 target genes, including an
intronic binding site in the Foxp3 locus8, an Il7r enhancer element11,12, as well as binding
sites in the proximal promoter regions of the Fbxo32 and Bcl2l11 genes19,20 (Supplementary
Fig. 9).
Foxo1 binding sites were mostly enriched in the promoters and the 5′ untranslated regions
(UTRs), whereas peaks mapped to the intergenic regions and 3′ UTRs were substantially
under-represented (Fig. 3c). Further analysis of the peaks showed that Foxo1 preferentially
bound to regions within 500 base pairs of the transcription start sites (Supplementary Fig.
8c). Foxo1 binding peaks were enriched for the high-affinity Foxo1 binding motifs, and de
novo motif prediction from the top 500 ranked binding peaks revealed a conserved Foxo1
recognition site (Supplementary Fig. 8d, e). In addition, approximately 73% of Foxo1
binding sites were mapped to the conserved genomic regions of mammalian species
(Supplementary Table 1). These observations support an evolutionarily conserved function
for Foxo1 in classical transcriptional regulation of target-gene expression.
To identify the cellular functions directly regulated by Foxo1 transcriptional control, we
performed gene-expression profiling on Treg cells from wild-type, Foxp3creFoxo1fl/fl,
Foxp3creFoxo1AAA/+ and Foxp3creFoxo1fl/fl Foxo1AAA/+ mice. Comparison of data from
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wild-type and Foxp3creFoxo1fl/fl Treg cells revealed 942 and 1,155 genes downregulated or
upregulated, respectively, by more than 1.5 fold, ~80% of which were corrected in
Foxp3creFoxo1fl/fl Foxo1AAA/+ Treg cells (Supplementary Table 2). By cross-referencing
this data set with the data set of Foxo1-bound genes, we identified 310 putative Foxo1 direct
target genes, among which 240 and 70 genes were activated or repressed, respectively, by
Foxo1 (Fig. 3d and Supplementary Table 3).
Treg cell homeostasis and function are dependent on the Treg-cell-specific transcription
factor Foxp3 (ref. 5). ChIP and genome tiling array studies have revealed Foxp3-bound
genes in murine T cells21,22. Approximately 6.8% or 9.6% of Foxo1-bound genes were
occupied by Foxp3 in Treg cells or in a T-cell line that overexpressed Foxp3 (Supplementary
Fig. 10a). Comparison of the putative direct target genes of Foxo1 and Foxp3 revealed that
~90% of activated genes and ~99% of repressed genes were specifically regulated by Foxo1
or Foxp3 (Supplementary Fig. 10b, c and Supplementary Table 3). Indeed, expression of the
Foxp3 target gene Il2ra (coding for CD25) was decreased in T cells transcribing a Foxp3
null allele that encodes a GFP reporter23, but not in Foxo1-deficient Treg cells (Fig. 4a and
Supplementary Fig. 10d). A recent study showed that Foxo1 binds to the promoter region of
the Foxp3 target gene Ctla4 (ref. 10). ChIP-seq experiments revealed weak Ctla4-promoter
binding of Foxo1 in antibody but not biotin samples (data not shown). In the absence of
Foxo1, CTLA4 was marginally downregulated, whereas the amount of Ctla4 transcript was
approximately fourfold lower in the absence of Foxp3 (Fig. 4a and Supplementary Fig. 10e).
Foxp3 and CTLA4 are essential for Treg cell inhibition of conventional T-cell proliferation
in vitro23,24. By contrast, as previously reported in ref. 11, Foxo1-deficient Treg cells had
normal suppressive activity in such assays (Fig. 4b). These observations imply that the
Foxp3-dependent program is largely intact in the absence of Foxo1, and the loss of
suppressive activity of Foxo1-deficient Treg cells is probably independent of CTLA4.
To gain insights into the general functional features of the Foxo1-regulated program, we
analysed the Gene Ontology and BioCarta pathway association of Foxo1 target genes25. The
putative Foxo1 direct target genes were strongly associated with cell communication, signal
transduction, transcription and metabolism, and were specifically enriched for genes
involved in the Jak-STAT, TCR and insulin-signalling pathways (Supplementary Table 4).
A salient characteristic of Treg cells is their inability to produce pro-inflammatory cytokines
such as IFN-γ. Foxo1 was recruited to a regulatory element located 22 kilobases upstream
from the transcriptional start site of the Ifng gene26 in Treg cells (Fig. 4c, d). In the absence
of Foxo1, IFN-γ messenger RNA and protein were highly induced in Treg cells (Fig. 4e, f
and Supplementary Fig. 11a). However, similar to wild-type Treg cells, Foxo1-deficient Treg
cells were unable to produce interleukin (IL)-2 (Supplementary Fig. 11b), which is probably
regulated by Foxp3 (ref. 22). To determine whether Foxo1 had a cell-intrinsic role in
inhibiting IFN-γ expression, we co-cultured wild-type Treg cells and Treg cells from the
disease-free creER Foxo1fl/fl mice previously treated with tamoxifen to acutely delete
Foxo1. A sizable fraction of Foxo1-deficient but not wild-type Treg cells produced IFN-γ
under the condition of IL-12 and IFN-γ stimulation (Supplementary Fig.12a). Importantly,
wild-type and Foxo1-deficient conventional CD4+ T cells produced similar amounts of IFN-
γ (Supplementary Fig. 12b), revealing a specific function for Foxo1 in repressing IFN-γ
expression in Treg cells.
To investigate whether IFN-γ production by Foxo1-deficient Treg cells contributed to their
loss of suppressive function, we crossed Foxp3creFoxo1fl/fl mice to the IFN-γ-deficient
background. Ablation of IFN-γ partially corrected the lethal inflammatory phenotype as well
as the lymphoproliferative disease of Foxp3creFoxo1fl/fl mice (Supplementary Fig. 13). To
assess the specific function of IFN-γ produced by Foxo1-deficient Treg cells, we used a
transfer model of colitis. Recipient mice deficient in recombination-activating gene 1
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(Rag1−/−) did not develop colitis upon receipt of wild-type, Foxo1−/− or Foxo1−/− Ifng−/−
Treg cells (Supplementary Fig. 14). However, recipients of naive T cells developed a wasting
disease and colitis within 4 weeks, which was prevented by wild-type but not Foxo1-
deficient Treg cells (Fig. 4g, h and Supplementary Fig. 14b). Importantly, the suppressive
activity was largely restored in Foxo1−/− Ifng−/− Treg cells (Fig. 4g, h and Supplementary
Fig. 14b), supporting Ifng as a critical Foxo1 target gene in the control of Treg cell function.
Foxo proteins control Foxp3 expression and Treg cell differentiation8–10. Our new data
reveal that the Akt–Foxo1 signalling pathway is modulated in mature Treg cells to maintain
high nuclear Foxo1 activity; this is crucial for Treg cell function, in part through Foxo1
inhibition of IFN-γ expression. IFN-γ produced by Treg cells may activate conventional T
cells or antigen-presenting cells compromising Treg cell function, but the precise
mechanisms remain to be determined. Diminished TCR-induced Akt activation has been
observed in human Treg cells27, suggesting that Foxo1 controls human Treg cell function.
Under conditions of strong TCR stimulation, nuclear Foxo1 is translocated to the cytosol in
Treg cells, raising the possibility that the Foxo1-dependent program is subject to regulation.
Intriguingly, Treg cells from mice infected with Toxoplasma gondii produce IFN-γ28.
Increased frequencies of IFN-γ-secreting Treg cells are also present in multiple sclerosis and
diabetes patients29,30. Future studies will determine whether the loss of Foxo1 function
accounts for Treg cell plasticity under these pathological conditions, and whether the Akt–
Foxo1 signalling pathway can be manipulated for the treatment of Treg-cell-associated
immunological disorders.
METHODS
Mice
To generate a Foxo1 knock-in mouse model (Foxo1tag), two genomic DNA fragments of the
Foxo1 gene were isolated from a C57BL/6 bacterial artificial chromosome library (Genome
Systems). A cDNA coding for GFP, Flag and biotin-labelling peptide was inserted into the
genomic DNA fragment containing the second exon of Foxo1 before the stop codon.
Targeting vector was constructed by cloning the fragments into pEasy-Flox plasmid. To
generate a Rosa26-hFoxo1AAA knock-in mouse model (Foxo1AAA), the cDNA coding for a
HA-tagged human Foxo1 (AAA) mutant was inserted into a Rosa26 targeting vector.
Linearized targeting vectors were transfected into embryonic stem cells derived from the
C57BL/6 strain. Homologous recombinants were identified by Southern blotting analysis,
and were implanted into foster mothers. Chimaeric mice were bred to C57BL/6 mice, and
the F1 generation was screened for germline transmission. The neo gene in Foxo1tag mice
was removed by breeding F1 mice with a strain of cytomegalovirus-promoter-driven cre-
transgenic mice (The Jackson Laboratory). Mice containing floxed Foxo1, Foxp3-IRES-
RFP, Foxp3Cre, Foxp3gfpko (Foxp3 null allele coding for a GFP reporter) and birA alleles
were previously described11,14,23,31,32. C57BL/6, Foxp3sf, Ifng−/−, Rag1−/− and UBC-cre-
ERT2 (creER) mice were purchased from the Jackson Laboratory. Mice with intact or
floxed Foxo1 alleles were used as wild-type controls. Mice with Treg-cell-specific deletion
of Foxo1 were generated by crossing Foxo1 floxed mice with Foxp3cre mice. To mark Treg
cells with RFP, mice were bred with Foxp3-IRES-RFP mice. To label Foxo1 with biotin,
Foxo1tag mice were bred with birA-transgenic mice. All mice were maintained under
specific pathogen-free conditions, and animal experimentation was conducted in accordance
with institutional guidelines.
Antibodies and immunoblotting
Anti-p-Foxo1 Thr 24 (no. 9464), anti-Foxo1 (C29H4), anti-p-Akt Ser 473 (D9E), anti-Akt
(C67E7), anti-p-Erk1/2, anti-Erk1/2 and anti-HA (6E2) were purchased from Cell Signaling.
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Anti-β-actin (AC-15) was obtained from Sigma. To determine Foxo1 expression in Treg
cells, CD4+Foxp3+ Treg cells were purified by FACS. Total protein extracts were dissolved
in SDS sample buffer. To assess Foxo1 translocation, T cells were stimulated with anti-CD3
and anti-CD28, and the cytosolic and nuclear extracts were prepared. To analyse Akt, Foxo1
and Erk phosphorylation, conventional CD4+ T cells and CD4+Foxp3+ Treg cells were
purified by FACS. T cells were stimulated with anti-CD3 and anti-CD28, and the total
protein extracts were prepared. Protein extracts were separated on 8% SDS–PAGE gels and
transferred to polyvinylidene difluoride membrane (Millipore). The membranes were probed
with antibodies and visualized with the Immobilon Western Chemiluminescent HRP
Substrate (Millipore).
Live imaging of Foxo1 translocation
CD4+ cells were isolated from Foxo1tag/tag Foxp3-IRES-RFP mice, and stimulated with
plate-bound anti-CD3 and anti-CD28 on glass surfaces. GFP, RFP and bright-field images
were acquired every 2 min after addition of cells using a fluorescence videomicroscope
(Olympus IX-81) fitted with a 40X objective lens. Nuclear Foxo1 clearance was quantified
by analysing two orthogonal linescans through each cell. For each linescan, the average
intensity of three equally spaced pixels inside the cell was divided by the average intensity
of the cell edge on each side to determine a `clearance ratio'. Nuclear exclusion leads to a
decrease in clearance ratio.
Immunofluorescence microscopy
CD4+ T cells were isolated from spleen and peripheral lymph nodes of C57BL/6 mice with
anti-CD4 microbeads (Miltenyi Biotec Inc.), stimulated with plate-bound anti-CD3 (low
dose, 0.01 μg ml−1; high dose, 0.1 μg ml−1) and anti-CD28 (1 μg ml−1) on chamber slides at
37 °C for 20 min. After fixation with 4% paraformaldehyde, cells were permeabilized with
Foxp3 Fixation/Permeabilization buffer (eBioscience) according to the manufacturer's
instructions. After blocking with Permeabilization buffer and 3% BSA, cells were incubated
with 1:250 diluted rabbit anti-Foxo1 (C29H4, Cell Signaling) and rat anti-Foxp3 (FJK-16 s,
eBioscience), followed by allophycocyanin (APC)-anti-rabbit and fluorescein isothiocyanate
(FITC)-anti-rat secondary antibodies in Permeabilization buffer and 1% BSA. Slides were
mounted with gold anti-fading mounting buffer (Invitrogen). Images were acquired with a
Leica TCS SP5-II confocal microscope. For quantitative analysis, five fields were selected
randomly and total cells in the field were manually counted and grouped with Volocity
software (PerkinElmer Inc.), on the basis of their Foxo1 nuclear or cytosolic localization and
Foxp3 expression.
Flow cytometry
Fluorescent-dye-labelled antibodies against cell-surface markers CD4, CD8, TCR-β, CD44,
CD62L, CTLA4 and CD25 were purchased from eBiosciences. Thymic, splenic and lymph
node cells were depleted of erythrocytes by hypotonic lysis. Cells were incubated with
specific antibodies for 30 min on ice in the presence of 2.4G2 monoclonal antibody to block
FcγR binding. All samples were acquired and analysed with an LSR II flow cytometer
(Becton, Dickinson) and FlowJo software (TreeStar). Intracellular Foxp3, CTLA4 and Ki67
stainings were carried out with kits from eBiosciences. To determine cytokine expression,
splenic and lymph node T cells were stimulated with 50 ng ml−1 phorbol 12-myristate 13-
acetate (Sigma), 1 μM ionomycin (Sigma) and GolgiStop (BD Biosciences) for 4 h. After
stimulation, cells were stained with cell-surface marker antibodies, fixed and permeabilized,
and stained with anti-Foxp3 in combination with specific antibodies against IFN-γ and IL-2
(eBiosciences).
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ELISA
Treg cells were purified from wild-type and Foxp3cre Foxo1fl/fl mice by FACS and
stimulated with CD3 and CD28 antibodies in the presence of IL-2 for 24 h. Cytokine
amounts in tissue-culture supernatants were assayed with ELISA antibody pair for IFN-γ
(eBioscience, 88-8312) in accordance with the manufacturer's recommendations.
In vitro T-cell differentiation
CreER-mediated deletion of floxed Foxo1 alleles was induced by intraperitoneal injection of
2 mg of tamoxifen (Sigma) emulsified in 200 ml of corn oil (Sigma) every day for 5 days.
CD4+Foxp3+ Treg cells or CD44loCD4+Foxp3− conventional T cells from CD45.1+ wild-
type and CD45.2+ tamoxifen-treated creER Foxo1fl/fl (Foxo1−/−) mice were isolated by
FACS and were co-cultured at 1:1 ratio with irradiated splenocytes, anti-CD3 (1 μg ml−1),
anti-CD28 (2 μg ml−1) and IL-2 (200 U ml−1) in the presence or absence of IL-12 (5 ng
ml−1) and IFN-γ (10 ng ml−1) for 3 days.
In vitro Treg cell suppression
CD44loCD4+Foxp3− conventional T cells labelled with CFSE were used as responder cells.
Responder T cells (5 × 104) were cultured for 72 h with irradiated splenocytes (1 × 105) and
anti-CD3 (2 μg ml−1) in the presence or absence of various numbers of Treg cells. The
division of responder T cells was assessed by dilution of CFSE.
Transfer model of colitis
Naive T cells sorted by FACS (CD4+CD44loCD62Lhi, 4 × 105) from CD45.1+ C57BL/6
mice were transferred into Rag1−/− mice alone or in combination with CD45.2+ Treg cells
(CD4+Foxp3+, 2 × 105). After T-cell reconstitution, mice were weighed weekly and
monitored for signs of disease. Mice were killed at 4 weeks after T-cell transfer and their
colons were used for histopathological analysis. The following grades were used to evaluate
their disease severity: 0, normal colonic crypt architecture; 1, mild inflammation: slight
epithelial cell hyperplasia and increased numbers of leukocytes in the mucosa; 2, moderate
colitis: pronounced epithelial hyperplasia, significant leukocyte infiltration, and decreased
numbers of goblet cells; 3, severe colitis: marked epithelial hyperplasia with extensive
leukocyte infiltration, significant depletion of goblet cells, occasional ulceration, or cryptic
abscesses; 4, very severe colitis: marked epithelial hyperplasia with extensive transmural
leukocyte infiltration, severe depletion of goblet cells, many crypt abscesses and severe
ulceration.
Histopathology
Tissues from killed animals were fixed in Safefix II (Protocol) and embedded in paraffin. 5-
μm sections were stained with haematoxylin and eosin.
ChIP-seq
Treg cells were fixed for 10 min at 25 °C with 10% formaldehyde. After incubation, glycine
was added to a final concentration of 0.125 M to `quench' the formaldehyde. Cells were
pelleted, washed twice with ice-cold PBS and lysed. The lysates were pelleted, re-suspended
and sonicated to reduce DNA length to 300–500 base pairs (bp). The chromatin prepared
from Treg cells of C57BL/6 mice was incubated with protein-A-anti-Foxo1 (ab39670,
Abcam) or an iso-type control antibody overnight. The chromatin prepared from Treg cells
of Foxo1tag/tagbirA Foxp3-IRES-RFP or control birA mice was incubated with streptavidin
overnight. The immune complexes were washed, and eluted in 500 ml of elution buffer
containing 50 μM Tris, 10 mM EDTA and 1.0% SDS. Precipitated ChIP DNA and input
DNA were incubated at 65 °C to reverse the crosslinking. After digestion with RNase and
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proteinase K, the ChIP and input DNA were purified with phenol/chloroform extraction and
ethanol precipitation. The purified DNA was repaired, ligated with an adaptor, and amplified
by PCR for 15–20 cycles. The amplified DNA was purified by gel extraction and used for
sequencing. SR-36 sequencing was done at the Genome Center of Cold Spring Harbor
Laboratory.
Visualizing read densities and identifying binding sites
Uniquely mapped sequence reads (36 bp) were aligned to the mouse genome (July 2007,
NCBI37/mm9) using the Bowtie33 short-read alignment software (version 0.12.7).
Candidate binding sites were predicted using the MACS34 peak detection software (version
1.4.1). In brief, MACS determines regions of enrichment by building sequencing-density
profiles for sense and antisense reads, with respect to the reference, and pairing them such
that the average distance between pairings can be used to model the approximate library
fragment length (d). Reads from both strands were then repositioned by shifting a distance
half the estimated fragment length, ½d, downstream to capture the most likely binding
location at the fragment midpoint rather than skewing to the 5′ or 3′ ends. Enrichment was
then determined by scanning the shifted, genome-wide read profile with a window twice the
size of the estimated fragment length, where the number of shifted reads falling within this 2
× d window was assumed to follow a Poisson distribution, with a mean parameter
determined from the local background in the input sample. The empirical false-discovery
rate (eFDR) was fine-tuned using the noise ratio to maximize the effectiveness of the peak-
calling strategy. The noise ratio was defined as the number control IgG peaks overlapping
control BirA peaks (control overlaps) divided by the number of Foxo1 antibody peaks
overlapping Foxo1 biotin peaks (ChIP overlaps). A noise ratio threshold of 0.005 was
chosen as it corresponded to a large reduction in noise. To achieve this ratio, peak-calling
was performed at an eFDR of 0.01. As defined in ref. 34, false background peaks were
enumerated as the number of peaks called when swapping the input and ChIP sample. The
eFDR was then calculated as the number of peaks detected divided by the number of
background peaks detected. We, thus, determined a suitable threshold of P < 2.5 × 10−9 and
P < 5.0 × 10−6, yielding 19,904 and 61,180 significantly enriched loci for antibody- and
biotin-based ChIP-seq of Foxo1, respectively. To visualize read-density profiles, we
aggregated counts at each genomic position for uniquely mapped reads that were extended
to the estimate d. Counts were then smoothed with a moving average within a 200-bp sliding
window across the genome. Smoothed average counts were visualized near to genes of
interest using the R software package (http://www.R-project.org).
Associating peaks with gene features
To further refine our enriched loci, we corroborated peaks detected in antibody-based ChIP-
seq with those from our biotinylated-Foxo1 tag-based method. To accomplish this, we
distinguished high-confidence peaks by selecting for all `antibody' peaks overlapped by one
or more `biotin' peaks and extending the 3′ and 5′ most coordinates to encompass all
overlaps, so as to reduce any redundancies. The merged coordinates yielded 3,431 high-
confidence, unique, merged regions, which we deemed putative Foxo1 binding sites. To
associate peaks with functional regions at high precision and resolution, we intersected
antibody peak summits (position of highest read density within a candidate peak region)
falling within high-confidence corroborated regions with the set of genomic features (for
example, 5′ UTR, 3′ UTR, exons, introns, 5-kilobase promoter, intergenic space) obtained
from the UCSC Table Browser35 (http://genome.ucsc.edu/). We also compared our regions
with conserved phastCons scores and elements (Euarchontoglire subset)36. Over-
representation of these features was estimated empirically by generating 1,000 background
sets each containing 3,431 random peaks, maintaining the same distribution of chromosomes
and widths as our high-confidence set. Peaks from each background set were assigned to
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appropriate functional categories. The significance of the observed number of each
annotation from our high-confidence summits was then inferred using a Z-test with respect
to these randomly generated background counts.
DNA motif analysis
We first extracted nucleotide sequences±250 bp flanking all antibody-based ChIP-seq
summits associated with peaks corroborated by biotinylated-Foxo1 tag-based ChIP-seq
enrichment. These DNA sequences were screened for over-representation of known
consensus motifs, using both the JASPAR37 and TRANSFAC38 databases, and the most
enriched known motifs were noted. To examine to what extent the consensus Foxo1
TRANSFAC motifs, M00473 and M00474 were enriched, we ranked our putative binding
site candidates by P value and assessed the cumulative occurrence rate one peak at a time,
from most to least enriched. This was done to illustrate the expectation that the cumulative
motif occurrence rate approaches the number of peaks with a motif divided by the total
number of peaks but would be significantly increased in more enriched subset of binding
candidates. Occurrence was determined using the STORM motif analysis tool available in
the CREAD software package39 at a threshold of P<1×10−4. We further substantiated the
over-representation of consensus Foxo1 motifs by performing de novo motif prediction from
the top 500 ranked candidate binding site sequences using the GADEM40 motif-discovery
algorithm, compared to shuffled sequences with similar di-nucleotide composition as
background. Statistical similarity of predicted de novo motifs was estimated using the
Tomtom41 motif comparison software available as part of the MEME software suite.
Gene-expression profiling
Treg cells were isolated from the spleens and peripheral lymph nodes of Foxp3creFoxo1fl/fl,
Foxp3creFoxo1AAA/+, Foxp3creFoxo1fl/fl Foxo1AAA/+ and wild-type mice by FACS. RNA
was prepared with the miRNeasy Mini Kit according to the manufacturer's instructions
(Qiagen). Two rounds of RNA amplification, labelling and hybridization to M430 2.0 chips
(Affymetrix) were done at the Core Facility of Memorial Sloan-Kettering Cancer Center.
Microarray data analysis
Microarray data was analysed using the R statistical software package. To reduce technical
variations from array to array, chip normalization was performed using robust multi-array
analysis available via the affy BioConductor package and differential gene expression
defined by 1.5-fold change with a false-discovery rate of <0.01 was determined using the
limma package42,43. When multiple probes for a given gene were significantly differentially
expressed, their log2-fold changes were averaged.
qPCR
mRNA amounts of Ifng, Il2ra, Ctla4 and Actb were determined by qPCR with the following
primers: Ifng, 5′-gcgtcattgaatcacacctg-3′ and 5′-tgagctcattgaatgcttgg-3′; Il2ra, 5′-
gagacttcctgccccataac-3′ and 5′-gccactgctaccttatactcc-3′; Ctla4, 5′-tggactccggaggtacaaag-3′
and 5′-aaacggcctttcagttgatg-3′; Actb, 5′-ttgctgacaggatgcagaag-3′ and 5′-
acatctgctggaaggtggac-3′. The mRNA amounts were normalized to those of Actb. Chromatin
amounts of the Foxo1 binding site in the Ifng locus were determined by qPCR with the
following primers: 5′-gacctgcacttctgtgagca-3′ and 5′-tctccttcctgtggatcacc-3′.
Heat-map
To effectively visualize Foxo1-dependent gene expression, we gated relative expression
values on wild-type versus Foxp3creFoxo1AAA/+ values; that is, the log2-fold change
between wild-type versus Foxp3creFoxo1AAA/+ was used to define a wild-type value equal
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to½log2-fold-change and a Foxp3creFoxo1AAA/+ value equal to ½ log2-fold change. The
remaining Foxp3creFoxo1fl/fl and Foxp3creFoxo1fl/fl/Foxp3creFoxo1AAA/+ fold-change
values were then similarly normalized with respect to this new wild-type value. We focused
on the range of genes within±2 log2-fold change; values exceeding this range at the
extremes were coloured blue or yellow. A selection of genes was depicted in which the
Foxp3creFoxo1fl/fl phenotype was partially or completely rescued by Foxp3creFoxo1AAA/+,
and putative Foxo1 binding sites, as determined by ChIP-seq experiments, resided nearby.
Gene-set enrichment analysis
Gene set and pathway analysis was performed using the FatiGO44 tool via the Babelomics25
software suite (http://babelomics.bioinfo.cipf.es) on Foxo1-bound target genes showing
differential gene expression rescued by Foxp3creFoxo1AAA/+. Significantly over-represented
categories were defined by an adjusted P value of 0.05 or less. We highlighted a selection of
Gene Ontology categories and BioCarta pathways made available on the Babelomics web-
based tool in our analysis.
Statistical analysis
Student's t-test was used to calculate statistical significance for difference in a particular
measurement between groups. A P value of <0.05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Foxo1 expression and TCR-induced Foxo1 nuclear exclusion in Treg cells
a, Foxo1 fusion protein with a tag containing GFP, Flag and a biotin-labelling peptide (top).
Flow cytometric analysis of Foxo1–GFP expression in thymic CD4+CD8+ double-positive T
cells (Thy DP), CD4+Foxp3− single-positive T cells (Thy SP) and CD4+Foxp3+ Treg cells
(Thy Treg), and splenic CD4+Foxp3− conventional T cells (CD4) and CD4+Foxp3+ Treg
cells from Foxo1tag/tag mice (Treg) (bottom). Cells from wild-type mice were used as a
control. b, c, TCR-induced Foxo1 nuclear clearance in CD4+RFP− conventional (Tcon) and
CD4+RFP+ Treg cells from Foxo1tag/tag mice. Cells were stimulated with 0.01 μg ml−1 (low)
or 0.1 μg ml−1 (high) anti-CD3 antibody (Ab) in the presence of 1.0 μg ml−1 anti-CD28. b,
Quantification of Foxo1 nuclear clearance. Nuclear exclusion leads to a decrease in
clearance ratio. c, Representative images of Foxo1 nuclear clearance of Tcon and Treg cells.
d, Phosphorylated (p)-Foxo1 Thr 24, total Foxo1, p-Akt Ser 473, total Akt, p-Erk1/2 and
total Erk1/2 proteins in Tcon and Tcon cells stimulated with low anti-CD3 and anti-CD28
were determined by immunoblotting. The relative amounts of p-Foxo1, p-Akt and p-Erk1/2
proteins normalized to total Foxo1, Akt and Erk1/2 proteins are shown. Error bars represent
s.d.; all experiments were repeated at least three times with similar results.
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Figure 2. An essential role for Foxo1 in the control of Treg cell function
a, Foxo1 protein in CD4+Foxp3− conventional (Tcon) and Treg cells from wild-type (WT)
and Foxp3creFoxo1fl/fl mice was determined by immunoblotting. β-actin was used as a
loading control. b, Images of 21-day-old wild-type, Foxp3sf and Foxp3creFoxo1fl/fl mice.
Arrows indicate the scurfy tails of Foxp3sf and Foxp3creFoxo1fl/fl mice. c, A representative
picture of spleens and peripheral lymph nodes from 20-day-old wild-type and
Foxp3creFoxo1fl/fl mice. d, Haematoxylin and eosin staining of salivary gland, lung, liver,
pancreas, stomach and colon sections from 21-day-old wild-type and Foxp3creFoxo1fl/fl
mice. e, CD4+ and CD8+ T-cell numbers from spleens and peripheral lymph nodes (pLN) of
17–21-day-old wild-type and Foxp3creFoxo1fl/fl mice (n=8 per genotype). f, Flow
cytometric analysis of CD44 and CD62L expression in peripheral lymph node CD4+ and
CD8+ T cells from 20-day-old wild-type and Foxp3creFoxo1fl/fl mice. g, Peripheral lymph
node T cells from 20-day-old wild-type and Foxp3creFoxo1fl/fl mice were stimulated with
phorbol myristate acetate (PMA) and ionomycin for 4 h. The expression of IFN-γ in CD4+
and CD8+ T cells was determined by intracellular staining. h, Flow cytometric analysis of
Foxp3 expression in peripheral lymph node CD4+ T cells from 20-day-old wild-type and
Foxp3creFoxo1fl/fl mice (left). Peripheral lymph node Treg cell numbers from 17–21-day-old
wild-type and Foxp3creFoxo1fl/fl mice (right; n=8 per genotype). The P values between the
two groups are shown. Asterisk indicates a statistically significant difference. Results
represent at least three independent experiments.
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Figure 3. Foxo1-dependent transcriptional programs in Treg cells
a, A schematic representation of the mouse line expressing HA-hFoxo1(AAA) specifically
in Treg cells. A cassette containing a floxed stop sequence, a cDNA coding for a HA-tagged
human Foxo1(AAA) mutant, and IRES-GFP proteins was inserted into the Rosa26 locus.
Mice with the knock-in allele were crossed with Foxp3cre mice (top). The expression of HA-
FOXO1(AAA) was determined by immunoblotting with anti-HA. β-actin was used as a
loading control (bottom). b, Survival of wild-type, Foxp3creFoxo1fl/fl and
Foxp3creFoxo1fl/flFoxo1AAA/+ mice (n=6 to 10 per genotype). c, The overlapping set of
peaks shared between antibody and biotin ChIP-seq samples was associated with functional
annotations based on the genomic location of the summits within each peak, which revealed
enrichment in gene promoters (P=0.04) and 5′ UTRs (P<1×10−10) above the background
rate using randomly generated peaks. d, Foxo1-bound target genes differentially expressed
between wild-type and Foxp3creFoxo1fl/fl Treg cells, and whose expression was corrected in
Foxp3creFoxo1fl/flFoxo1AAA/+ Treg cells.
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Figure 4. Restoration of Foxo1-deficient Treg cell function in the absence of IFN-γ
a, Flow cytometric analysis of Foxp3, CD25 and CTLA4 expression in lymph node Treg
cells from 20-day-old wild-type and Foxp3creFoxo1fl/fl mice. b, Suppression of wild-type
naive CD4+ T cells, labelled with the cytosolic dye carboxyfluorescein diacetate
succinimidyl ester (CFSE) (responding T cells (Tresp)), by wild-type and Foxo1-deficient
(Foxo1−/−) Treg cells. Tresp cell division was assessed by CFSE dilution at the indicated
ratios of cell numbers between Treg cell and Tresp cells. c, Foxo1-bound regions in the Ifng
locus. d, Foxo1 binding to the ChIP-seq peak was confirmed by ChIP-quantitative (q)PCR,
and is presented relative to enrichment by immunoprecipitation with isotype-matched
control antibody. e, Expression of IFN-γ mRNA in Treg cells from wild-type and
Foxp3creFoxo1fl/fl mice was determined by qPCR. f, Peripheral lymph node T cells from 20-
day-old wild-type and Foxp3creFoxo1fl/fl mice were stimulated with PMA and ionomycin
for 4 h. The expression of IFN-γ in Treg cells was determined by intracellular staining. g, h,
Naive T cells (N) were transferred to Rag1−/− mice alone or in combination with wild-type,
Foxo1−/− or Foxo1−/− Ifng−/− Treg cells. Changes in body weight of Rag1−/− recipients over
time are shown (n=4) (g). Haematoxylin and eosin staining of colon sections from Rag1−/−
mice at 4 weeks after the transfer (h). Error bars represent s.d.; results are representative of
at least three independent experiments.
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